Pear Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2021 to Q1 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Pear Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2022.
- Pear Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$36.7M, a 75.1% decline year-over-year.
- Pear Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$114M, a 4.45% decline from 2021.
- Pear Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$109M, a 60.6% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)